SEC Form D · Amendment · filed July 16, 2021
Gaiamer Biotechnologies, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Araya Mesfin · Atlanta, GADirectorJerry Schindler · Acworth, GADirectorThomas Trimbach · Los Angeles, CAExec · DirectorKeith Tinsley · Bellflower, CAExec · DirectorChristopher Sargent · Flushing, MIExec · DirectorCharles Caliman · Los Angeles, CAExec · DirectorJihene Dhaouadi · Long Beach, CADirectorGareth H. Jenkins · New York, NYDirectorRaphael A. Martorello · Denver, COExec · DirectorGrayBul Tyde GP LLC · Greenville, SCDirectorJerry H. Schneider · New York, NYExec · DirectorRosemarie H. Fanelli · New York, NYExec · DirectorAaron L. Kaplan · New York, NYDirectorBenjamin S. Kaplan · New York, NYExec · DirectorWilliam B. Morris · Knoxville, TNExec · DirectorPaul Hsu · Dover, DEDirectorAlejandro Zecler · Grand Cayman, Cayman IslandsExec · DirectorMario Ruiz · Emerald Hills, CADirectorNardo N. Manaloto Jr · Pasadena, CAExec · DirectorKelly Cornelis · Chicago, ILDirectorAntti Vuori · VANCOUVER, British Columbia, CanadaExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗